Involvement of NADPH oxidases in cardiac remodelling and heart failure

Area of Science:

• Cardiovascular biology
• Molecular medicine
• Redox signaling

Background:

• Cardiac remodelling, characterized by hypertrophy, fibrosis, and dysfunction, precedes heart failure.
• Oxidative stress is increasingly recognized as a key driver of adverse cardiac remodelling.
• NADPH oxidase (Nox) enzymes generate reactive oxygen species (ROS) involved in cellular signaling.

Purpose of the Study:

• To review the evidence linking NADPH oxidases to various aspects of detrimental cardiac remodelling.
• To explore the role of Nox enzymes in the molecular mechanisms underlying heart failure development.

Main Methods:

• Literature review of studies investigating NADPH oxidase involvement in cardiac remodelling.
• Analysis of research on ROS generation and redox signaling in cardiovascular stress responses.

Main Results:

• NADPH oxidases are significant sources of ROS implicated in pathological cardiac remodelling.
• Evidence suggests Nox enzymes contribute to hypertrophy, fibrosis, and contractile dysfunction in the heart.
• Nox-derived ROS play a critical role in redox signaling pathways activated by cardiac stress.

Conclusions:

• NADPH oxidases are key players in the development of adverse cardiac remodelling.
• Understanding Nox enzyme function offers potential for novel heart failure therapeutic targets.
• Targeting Nox-mediated oxidative stress may prevent or mitigate heart failure progression.